Robert Dale, MD
Family Practice · Amory, MSNPI 1215041652
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 38 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by AstraZeneca at 31.7% of the total. 2023 is the largest year on record at $265, 2.2 times the $119 reported in 2019. Among family practice clinicians in MS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 38 payments — averaging $20.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$247
- Bayer$181
- Lilly USA, LLC$111
- Boehringer Ingelheim$64
- AbbVie$48
- Novo Nordisk$32
- plus $97 from 4 others
What the payments were for
- Food & beverage$780100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 6 | $247 |
| Bayer | 9 | $181 |
| Lilly USA, LLC | 8 | $111 |
| Boehringer Ingelheim | 4 | $64 |
| AbbVie | 3 | $48 |
| Novo Nordisk | 2 | $32 |
| Amgen | 2 | $31 |
| Mylan Specialty L.p. | 2 | $30 |
| Bausch Health US, LLC | 1 | $19 |
| Johnson & Johnson | 1 | $17 |
How this compares
$780 in reported general payments places this provider in the 95th percentile of 36 family practice providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 11 | $141 |
| ClopidogrelClopidogrel Bisulfate | 15 | $133 |
| Atorvastatin Calcium | 11 | $78 |
Paid to pharmacies, not to this prescriber.
Other family practice in Amory
- Charles BorumNatchez$2K
- Luke CampbellTupelo$482
- Joe PulliamGreenville$423
- Justin DukeTupelo$353
- Carla ArmstrongTylertown$344
- Ashley AlphonseJackson$194
- Sharon CollinsTylertown$111
- Chinedu IfejiagwaJackson$44
- Christian BeebeChoctaw$0
- Matthew CapalboLucedale$0
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.